Cargando…
Carrier Effect in Development of Rifampin Loaded Proliposome for Pulmonary Delivery: A Quality by Design Study
Purpose: Pulmonary tuberculosis (TB) is a worldwide life-threatening infection. Therecommended anti-TB regimen contains oral administration of classical first-line drugs suchas rifampin for 6-24 months which often leads to low patient compliance due to high adverseeffects; therefore, lung localized...
Autores principales: | Parhizkar, Elahehnaz, Sadeghinia, Delaram, Hamishehkar, Hamed, Yaqoubi, Shadi, Nokhodchi, Ali, Alipour, Shohreh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106949/ https://www.ncbi.nlm.nih.gov/pubmed/35620341 http://dx.doi.org/10.34172/apb.2022.032 |
Ejemplares similares
-
Carrier-Free Inhalable Dry Microparticles of Celecoxib: Use of the Electrospraying Technique
por: Jahangiri, Azin, et al.
Publicado: (2023) -
Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension
por: Zendehdel Baher, Shalaleh, et al.
Publicado: (2022) -
Design and Characterization of Spray-Dried Proliposomes for the Pulmonary Delivery of Curcumin
por: Adel, Islam M, et al.
Publicado: (2021) -
Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor
por: Khan, Iftikhar, et al.
Publicado: (2023) -
Formulation Development and in vitro Characterization of Proliposomes for Topical Delivery of Aceclofenac
por: Gupta, Vandana, et al.
Publicado: (2008)